rgupta
Regular
Interestingly when brn and LKE moved to asx 200 everyone was saying shorters will kill both these companies.
And see both the company's sp is way down and shorters at all time high
BRN Discussion Ongoing
- Thread starter TechGirl
- Start date
And see both the company's sp is way down and shorters at all time high
Frangipani
Regular
Here is another post liked by Nandan Nayampally on LinkedIn, posted by a California internist, who is a specialist in pulmonary and critical care medicine:
View attachment 38866
I googled the hospital, which serves the Napa Valley area (excellentregion!) and discovered the following Spring/Sommer 2023 hospital newsletter with more info on the said lung nodule programme:
View attachment 38867
View attachment 38868
View attachment 38869
How probable is it that Nandan, who resides in Austin, Texas, wouldthis post about a newly launched “lung nodule programme” by an MD at a California hospital on a six-month demo trial with a state-of-the-art robotic-assisted bronchoscopy system, raising funds for “an Artificial Intelligence System to detect signs of cancerous lung nodules up to a year earlier than manual-only review of x-rays” without Brainchip being involved?!
Just a follow-up on my post above:
You’d expect cutting-edge technology/research to be mainly used/conducted at major academic centres such as university hospitals rather than at small rural hospitals such as the one in St. Helena, CA.
As for their use of a robotic-assisted bronchoscopy system as such, I am not too surprised, as Napa County must surely rank among the most affluent areas in the US, and even the hospital in a town with a population of about 60,000 close to where I live in Germany has been a da Vinci Centre (the state-of-the-art robotic surgical system manufactured by Intuitive Surgical that uses a minimally invasive surgical approach) for more than a decade, with robotic-assisted surgeries performed by urologists, gynaecologist as well as general surgeons.
But why would a pulmonary and critical care specialist at a relatively small rural hospital be involved in a cutting-edge AI project? Well, first of all I would reply “Why not?!” Foresighted visionaries can be found anywhere!
He might have come across the benefits this particular AI system offers by reading about it, by learning about it from colleagues at conferences or while working at another hospital prior to joining the one in St. Helena. And thanks to a relatively wealthy clientele that is generously donating, funding doesn’t appear to be the unsurmountable obstacle it is for less fortunate institutions.
Yet another possibility would be that he came across Brainchip’s revolutionary technology (on the assumption that this particular yet to be fully funded Artificial Intelligence System will have Akida incorporated) through a different channel, namely thanks to a network that should not be underestimated. Judging from his name and outward appearance, Dr. Kiran Madhav Ubhayakar has Indian roots, and so do both Nandan Nayampally and Anil Mankar (who emigrated to the US after graduating from the renowned IIT Bombay).
I have close Indian American friends in Southern California (very cliché-like they are of course all doctors or lawyers
) and thus know very well how closely-knit the Indian community in the US is. And while India is a huge and diverse subcontinent, it seems to me that even to second- or third-generation immigrants it ultimately doesn’t matter whether you come from a Hindi, Gujarati, Marathi, Tamil or Malayalam-speaking background, as bonding over common Indian cultural (and religious) heritage such as enjoying culinary delicacies (whether biryani, butter chicken, chana masala, fish curry, naan or dosa), celebrating Diwali/Deepavali, watching Bollywood movies and music videos or upholding Indian wedding traditions is ultimately more important than emphasising the differences in their Indian backgrounds.Note that Dr. Ubhayakar “received his medical degree from the University of Texas Medical Branch in Galveston, Texas, and completed his internship in internal medicine and pediatrics at the University of Texas Health Science Center at Houston. Ubhayakar completed his internal medicine residency at the University of Texas Medical Branch, and his fellowship in pulmonary and critical care at the University of Texas Southwestern in Dallas, Texas.”
Both Dallas and Houston are thriving hubs of the Indian-American community, and Nandan Nayampally lives in Austin, TX (according to his LinkedIn profile), not too far from Houston.
Less likely from a geographical point of view would be a connection through Anil Mankar, who lives in CA, just like Dr. Ubhayakar, although some 750 km (466 miles) south of him. Then again, info along the Indian information grapevine can travel large distances at high speed.
Of course a possible connection via the Indian-American community is pure speculation, and we don’t even know whether or not Akida is involved. But keep in mind that business and private networks absolutely encourage cross-pollination, both on a local and on a global stage, with the rise of the internet age obviously having been a massive accelerator.
And even if Dr. Ubhayakar has not yet heard of Brainchip and Akida, one thing is for sure: Robotic surgery will undoubtedly play an increasingly important role in the future of medicine. Integrating AI will allow for improved diagnostics and decision-making and enable surgeons in many cases to diagnose and operate in one session, which will in turn save those patients precious time and lessen anxiety, as they won’t have to wait for their biopsy results first and - in case a tumour is found - make another appointment for surgery. And improved AI diagnostics (“System to detect signs of cancerous lung nodules up to a year earlier than manual-only review of x-rays”) will lead to many lives saved or at least prolonged - another amazing use case of Beneficial AI!
Napa biz buzz: Ubhayakar joins Adventist Health Physicians Network St. Helena
From the Biz Buzz: Napa Valley business news roundup series
Oct 11, 2022 Updated Jun 22, 2023
6340b22701eab.image.jpg.webp
Dr. Kiran Ubhayakar
FOR THE REGISTER
Adventist Health announced that Dr. Kiran Ubhayakar, board-certified pulmonary and critical care specialist, has joined its staff.
Ubhayakar is board-certified in internal medicine, pulmonary medicine and critical care medicine, with special interest in critical care, endobronchial ultrasound and robotic navigational bronchoscopy.
Ubhayakar received his medical degree from the University of Texas Medical Branch in Galveston, Texas, and completed his internship in internal medicine and pediatrics at the University of Texas Health Science Center at Houston. Ubhayakar completed his internal medicine residency at the University of Texas Medical Branch, and his fellowship in pulmonary and critical care at the University of Texas Southwestern in Dallas, Texas.
He specializes in the diagnosis and treatment of conditions such as asthma, COPD, interstitial lung disease, pulmonary hypertension and lung cancer.
Last edited:
Tothemoon24
Top 20
Impacts of technology that has emerged over the past years include:
Material science
Renesas shifted from ceramic based substrates to measure gasses in the air to silicon based that significantly reduce size, cost, and improve reliability. Additional optical technologies have seen reduction in size and improved performance detecting both particulates as well as Carbon Dioxide.
Artificial Intelligence (AI)
The ability to use machine learning algorithms, such as neural networks to quantify targeted performance has enabled firmware configurable platforms providing rapid improvements in output, adherence to emerging standards and ultra-low power for battery powered applications. A Renesas team of engineers have released 10+ firmware AI configurations that use the same hardware and change the behavior of the sensors.
Economies of scale
Millions of low-cost sensors are being shipped driving down the cost of systems and enabling consumers to monitor their air quality without significant investments. Air quality sensors are now found in HVAC systems, Smoke Detectors, Conference Room equipment, Wireless Access points and Thermostats.Standards for indoor air quality are emerging but still not universally accepted. In the United States the White House had a summit in October advocating standards and actions targeting air quality in public buildings https://www.whitehouse.gov/cleanindoorair/ . Several of the leading IAQ definitions:
Umweltbundesamt (UBA)
German Environmental Agency had two indoor air quality (IAQ) studies over the past 20 years that provided a definition of IAQ as well as how long an individual should be exposed to it. The latest study has 5 levels of VOC pollutants as well as other IAQ pollutants that require consideration. Renesas’ ZMOD4410 is calibrated to this standard using Ethanol as a gas proxy. As the scale of gasses is quite high, this is a very good air quality definition supporting home use where kitchens, bathrooms and cleaning products typically can significantly elevate poor air quality.
WELL Standard
Over the past several years, the WELL Building standard has seen strong adoption in commercial buildings, schools, and public indoor areas. The difference between the UBA standard and WELL standard is that the levels of acceptable gasses in extremely low for WELL. This is a definition that is measured in parts per billion (ppb) and is either acceptable or not acceptable. The goal of this definition and sensors is to trigger HVAC systems to always ensure safe air quality.
RESET standard
This is an IAQ standard that is seeing strong growth in Asia. Over the past years much attention was paid to particulates but not gasses, you could see this by people wearing masks when outside. Indoor gasses as well as particulates are now being targeted as air purifiers integrated into HVAC systems or standalone can remediate many of these gasses.Air quality can be a tricky problem to solve as it is multi-dimensional. This means that Renesas Sensors can quantify gasses and then have their values change by the introduction of other gasses. This is the situation when oxidizing and reducing gases come together. In an indoor environment we quantify VOC levels (reducing gases). When a window is opened or air is drawn in from the outside, the introduction of Ozone which interacts with VOC’s. Ozone is an oxidizing gas and will reduce the level of VOC’s in a building. This may sound like a positive influence, but the concentration of ozone and how it impacts the baseline measurements of gas sensors is an issue. Changing the baseline of an IAQ sensor with an oxidizing gas will then bias the baseline used to report IAQ. We need to maintain a correct baseline of air quality to quantify levels of all pollutants and report to standards. In the illustration below, we can see a baseline shift due to Ozone entering a building as well as the sensors available to solve this problem. By using Renesas’ ZMOD4510, selective Ozone sensor with a ZMOD4410 VOC sensor calibrated to a standard and using a compensation engine, the baseline can be adjusted, and accurate reporting will continue with standards output. Also, elevated levels of Ozone can have a greater impact on health than the VOCs themselves, triggering respiratory issues. Thus, presenting a more complete picture of all pollutants is beneficial.
The solution requires several sensors and compensation engines to measure gasses found indoors as well as outdoors. When reporting to a very low-level ppb measurement, such as the WELL standard we also need relative humidity (RH) and temperature (T) sensors with compensation engines. Fortunately, this is a problem that we can solve with Renesas’ ZMOD4410, ZMOD4510 and HS4003 sensors.
Starting point for you design in start and prototyping should be
The Renesas Indoor Air Quality Sensor Platform Evaluation Kit with ZMOD4410-EVK or ZMOD4510-EVK or the US082-ZMOD4510EVZ board, which enables quick prototyping of the ZMOD4510 gas sensor module for outdoor air quality (OAQ) in a custom system design.
With low-cost sensors, AI and compensation engines the last piece of the puzzle is defining an acceptable air quality. Fortunately, there are groups that have provided studies with clear indoor air quality definitions as well as HVAC industry organizations pushing for agreed upon standards. Over the next several years we will have the ability quantify our air and have systems make decisions on our behalf. AI solutions will decide if outdoor air should be brought into the building based on the Outdoor Air Quality (OAQ) or recirculated using air purifiers that remove harmful gasses. Both neurological and cardiovascular diseases will see a sharp decrease because of measuring and remediating poor air quality. The technology, commercial viability and emerging definitions of standards will ensure that our environment is monitored, and we move on from the time in the 1940’s when we recognized a problem but had no options to solve it.
Digital Gas Sensor Platform (ZMOD)
Renesas’ Digital Gas Sensor ZMOD family provides a range of integrated digital sensor modules that provide best-inclass performance and reliability stability. In addition to being chemically and electrically calibrated, the platform’s flexible interface enables embedded AI and neural network trained software for configurable indoor, outdoor, and refrigeration air quality sensing solutions for sensing VOCs, ozone and NOx gases.Yeah, I think we were suddenly promoted to the premier league, but hadnt quite got our club in order... plus it became clear that our timeline to revenue was taking longer than previously anticipated. Also with the NDA's in place, there was little chance of a surprise / positive announcement. I think it was a no brainer for the shorters. Certainly, I didn't piece it all together. But this is the market. It's just money moving around based on sentiment and timing.
I believe in the product, the company and that significant revenue is coming.
I'm certainly in the red at the moment. But that comes down to my inexperience (15 years only) with investing. But I'm not selling. Fortunately I have several more years to wait for this to mature.
But, I do have a fairly good grasp on the technology, how it works, what it achieves and the many many use cases for it. This is not a piece of consumer tech that sells off the shelf by itself... it needs to be combined within an ecosystem of components. Akida is just a small but powerful part of a chain of components. But it's purposely made that way, to be ubiquitous and technologically agnostic.
BRN operates as an IP, business to business model... which is far more complex and likely to be very choppy at the beginning of a new technology life cycle in a new sub industry.
The tech is, in my opinion, going to be deployed in such a vast array of other technologies, in the future. How long before we know its being used? I don't think we will ever know. I'm sure most of us don't know what various companies produced the different components in your smart phone.
Incredibly complex and new tech takes considerable time to evaluate and test. Especially if it is incoperated in a product or service that has real world impacts for the individuals consuming it. For example, let's say akida is incorporated into a sensor that measures vibration as an early detection of wear and tear on a machine. This could have a considerable outcome on the users of that machine for safety and productivity. First the sensor has to be engineered and develop for the use case, the other components around the akida tech are added, and then tested in the real world. The machine might have a maintenance cycle of months to years.... so at least some of that time period will have to be tested in all sorts of different conditions, either in labs or in parallel with existing solutions already in place. And that's a pretty simple use case. Consider an automotive sensor? It has significant, life threatening implications, if it is not tested extensively. This is a technology that is literally involved in life and death decisions.
So why the delay in revenue? I think companies like mercades are rare, they are looking to get in on the ground with this tech and develop in house solutions. I think we will see ford do the same (hopefully with us) and maybe a few more innovative companies. But most other companies would be more than happy to let one of our licensees develop and test the broader solutions that akida can offer first and then do some minor tailoring to their needs closer to the final maturation of the tech. I think this is where the delay has been. I think the majority of our revenue will come from these bigger specialists in edge AI solutions. We just don't have the staff or resources at the moment to offer this service ourselves.
Eitherway, the tech is the real deal. It's going to be used, we have the patents on it... it's going to take time, but once revenue shows up, it will snow ball.
Just my opinion, do your own research.
I believe in the product, the company and that significant revenue is coming.
I'm certainly in the red at the moment. But that comes down to my inexperience (15 years only) with investing. But I'm not selling. Fortunately I have several more years to wait for this to mature.
But, I do have a fairly good grasp on the technology, how it works, what it achieves and the many many use cases for it. This is not a piece of consumer tech that sells off the shelf by itself... it needs to be combined within an ecosystem of components. Akida is just a small but powerful part of a chain of components. But it's purposely made that way, to be ubiquitous and technologically agnostic.
BRN operates as an IP, business to business model... which is far more complex and likely to be very choppy at the beginning of a new technology life cycle in a new sub industry.
The tech is, in my opinion, going to be deployed in such a vast array of other technologies, in the future. How long before we know its being used? I don't think we will ever know. I'm sure most of us don't know what various companies produced the different components in your smart phone.
Incredibly complex and new tech takes considerable time to evaluate and test. Especially if it is incoperated in a product or service that has real world impacts for the individuals consuming it. For example, let's say akida is incorporated into a sensor that measures vibration as an early detection of wear and tear on a machine. This could have a considerable outcome on the users of that machine for safety and productivity. First the sensor has to be engineered and develop for the use case, the other components around the akida tech are added, and then tested in the real world. The machine might have a maintenance cycle of months to years.... so at least some of that time period will have to be tested in all sorts of different conditions, either in labs or in parallel with existing solutions already in place. And that's a pretty simple use case. Consider an automotive sensor? It has significant, life threatening implications, if it is not tested extensively. This is a technology that is literally involved in life and death decisions.
So why the delay in revenue? I think companies like mercades are rare, they are looking to get in on the ground with this tech and develop in house solutions. I think we will see ford do the same (hopefully with us) and maybe a few more innovative companies. But most other companies would be more than happy to let one of our licensees develop and test the broader solutions that akida can offer first and then do some minor tailoring to their needs closer to the final maturation of the tech. I think this is where the delay has been. I think the majority of our revenue will come from these bigger specialists in edge AI solutions. We just don't have the staff or resources at the moment to offer this service ourselves.
Eitherway, the tech is the real deal. It's going to be used, we have the patents on it... it's going to take time, but once revenue shows up, it will snow ball.
Just my opinion, do your own research.
Fullmoonfever
Top 20
Do any of the really LTH know any other details of the early BRN and Veritone aiWare connection back in mid 2018?
Dead, alive, unknown?
I can see from the Ann back then it was to do more with Studio but that had the early elements of SNN from what I can see and was available for early access customers.
brainchip.com
I only ask (and only had time for cursory digging so far) as I saw a recent report on aiMotive aiWare being granted asil cert.
Now... I'm trying to find out if aiMotive aiWare and the Veritone aiWare are linked somewhere or one and the same or just doubled up on the name somehow?
www.veritone.com
Though, to be fair I can't find a specific SNN reference in aiWare...doesn't mean there is or isn't yet but more talk of CNN...that we can obviously convert though as we know.
aimotive.com
aimotive.com
Apparently Nextchip licensed aiWare for its Apache chip now as well.
The other thing I found was that emotion3D partnered with aiMotive mid last year and as we know, have now partnered with us early this year.
The two of them partnered with Nextchip on the Apache at the time as well.
www-globenewswire-com.translate.goog
Makes me ask was aiWare NPU just ok and Akida prob better or is there other interconnects in the background at play as well?
None of this can confirm much without something material between any of these and BRN to force a ASX Ann but I found all the intertwining interesting none the less.
Dead, alive, unknown?
I can see from the Ann back then it was to do more with Studio but that had the early elements of SNN from what I can see and was available for early access customers.
BrainChip Studio to be Integrated as a Cognitive Engine within Veritone aiWARE
Upon completion of the BrainChip Studio integration with aiWARE, customers will be able to access the unique capabilities of BrainChip Studio’s AI-powered object recognition and facial classification technology.
brainchip.com
I only ask (and only had time for cursory digging so far) as I saw a recent report on aiMotive aiWare being granted asil cert.
Now... I'm trying to find out if aiMotive aiWare and the Veritone aiWare are linked somewhere or one and the same or just doubled up on the name somehow?
Veritone | AI that makes you even better
Transform your workflows and superpower your teams with innovative, custom AI solutions, AI services, and a powerful enterprise AI platform.
Though, to be fair I can't find a specific SNN reference in aiWare...doesn't mean there is or isn't yet but more talk of CNN...that we can obviously convert though as we know.
aiMotive achieves an industry first milestone with ISO26262 ASIL B certification for aiWare4 NPU IP
aiMotive achieves an industry first milestone with ISO26262 ASIL B certification for aiWare4 NPU IP
We are thrilled to announce that our aiWare4 Neural Processing Unit (NPU) has achieved ISO 26262 ASIL B certification – making it the world’s first ASIL B certified NPU IP in the industry.
aiWare - aiMotive
NN Acceleration for Automotive AI
The aiWare NPU (Neural Processing Unit) is developed by engineers working side-by-side with our automated driving teams to create a unique solution targeting high performance L2-L4 automotive-grade real-time AI inference for AD/ADAS. The latest aiWare4+ IP delivers up to 1000 TOPS and industry-leading efficiency for a wide range of NN workloads including CNNs, LSTMs, RNNs and Transformer Networks.Apparently Nextchip licensed aiWare for its Apache chip now as well.
Production-proven hardware IP
Implemented for Nextchip Apache5 automotive production SoC; strong partnership leads to Nextchip licensing aiWare4 for next-generation Apache6 SoCThe other thing I found was that emotion3D partnered with aiMotive mid last year and as we know, have now partnered with us early this year.
The two of them partnered with Nextchip on the Apache at the time as well.
aiMotiveとemotion3Dが、Nextchip APACHE5上でaiWare NPU用に最適化されたドライバ監視ソリューションを提供
欧州主流の自動車テクノロジープロバイダー２社による協働により、魅力的なコストとパワーメトリクスで、素晴らしい性能のDOMS (ドライバと搭乗者監視システム) ソリューションが誕生...
aiMotive and emotion3D provide driver monitoring solution optimized for aiWare NPU on Nextchip APACHE5
Makes me ask was aiWare NPU just ok and Akida prob better or is there other interconnects in the background at play as well?
None of this can confirm much without something material between any of these and BRN to force a ASX Ann but I found all the intertwining interesting none the less.
I just love your in depth posts and commitment to ferreting out what can seem at times as obscure (maybe tenuous) relationships to Brainchip. But sometimes spot on and obvious to most all of us.Just a follow-up on my post above:
You’d expect cutting-edge technology/research to be mainly used/conducted at major academic centres such as university hospitals rather than at small rural hospitals such as the one in St. Helena, CA.
As for their use of a robotic-assisted bronchoscopy system as such, I am not too surprised, as Napa County must surely rank among the most affluent areas in the US, and even the hospital in a town with a population of about 60,000 close to where I live in Germany has been a da Vinci Centre (the state-of-the-art robotic surgical system manufactured by Intuitive Surgical that uses a minimally invasive surgical approach) for more than a decade, with robotic-assisted surgeries performed by urologists, gynaecologist as well as general surgeons.
But why would a pulmonary and critical care specialist at a relatively small rural hospital be involved in a cutting-edge AI project? Well, first of all I would reply “Why not?!” Foresighted visionaries can be found anywhere!
He might have come across the benefits this particular AI system offers by reading about it, by learning about it from colleagues at conferences or while working at another hospital prior to joining the one in St. Helena. And thanks to a relatively wealthy clientele that is generously donating, funding doesn’t appear to be the unsurmountable obstacle it is for less fortunate institutions.
Yet another possibility would be that he came across Brainchip’s revolutionary technology (on the assumption that this particular yet to be fully funded Artificial Intelligence System will have Akida incorporated) through a different channel, namely thanks to a network that should not be underestimated. Judging from his name and outward appearance, Dr. Kiran Madhav Ubhayakar has Indian roots, and so do both Nandan Nayampally and Anil Mankar (who emigrated to the US after graduating from the renowned IIT Bombay).
I have close Indian American friends in Southern California (very cliché-like they are of course all doctors or lawyers
Note that Dr. Ubhayakar “received his medical degree from the University of Texas Medical Branch in Galveston, Texas, and completed his internship in internal medicine and pediatrics at the University of Texas Health Science Center at Houston. Ubhayakar completed his internal medicine residency at the University of Texas Medical Branch, and his fellowship in pulmonary and critical care at the University of Texas Southwestern in Dallas, Texas.”
Both Dallas and Houston are thriving hubs of the Indian-American community, and Nandan Nayampally lives in Austin, TX (according to his LinkedIn profile), not too far from Houston.
Less likely from a geographical point of view would be a connection through Anil Mankar, who lives in CA, just like Dr. Ubhayakar, although some 750 km (466 miles) south of him. Then again, info along the Indian information grapevine can travel large distances at high speed.
Of course a possible connection via the Indian-American community is pure speculation, and we don’t even know whether or not Akida is involved. But keep in mind that business and private networks absolutely encourage cross-pollination, both on a local and on a global stage, with the rise of the internet age obviously having been a massive accelerator.
And even if Dr. Ubhayakar has not yet heard of Brainchip and Akida, one thing is for sure: Robotic surgery will undoubtedly play an increasingly important role in the future of medicine. Integrating AI will allow for improved diagnostics and decision-making and enable surgeons in many cases to diagnose and operate in one session, which will in turn save those patients precious time and lessen anxiety, as they won’t have to wait for their biopsy results first and - in case a tumour is found - make another appointment for surgery. And improved AI diagnostics (“System to detect signs of cancerous lung nodules up to a year earlier than manual-only review of x-rays”) will lead to many lives saved or at least prolonged - another amazing use case of Beneficial AI!
Napa biz buzz: Ubhayakar joins Adventist Health Physicians Network St. Helena
From the Biz Buzz: Napa Valley business news roundup series
Oct 11, 2022 Updated Jun 22, 2023
6340b22701eab.image.jpg.webp
Dr. Kiran Ubhayakar
FOR THE REGISTER
Adventist Health announced that Dr. Kiran Ubhayakar, board-certified pulmonary and critical care specialist, has joined its staff.
Ubhayakar is board-certified in internal medicine, pulmonary medicine and critical care medicine, with special interest in critical care, endobronchial ultrasound and robotic navigational bronchoscopy.
Ubhayakar received his medical degree from the University of Texas Medical Branch in Galveston, Texas, and completed his internship in internal medicine and pediatrics at the University of Texas Health Science Center at Houston. Ubhayakar completed his internal medicine residency at the University of Texas Medical Branch, and his fellowship in pulmonary and critical care at the University of Texas Southwestern in Dallas, Texas.
He specializes in the diagnosis and treatment of conditions such as asthma, COPD, interstitial lung disease, pulmonary hypertension and lung cancer.
But that quality is what makes this board both fun and informative. Thank you.
And your presence allows for me to notice FF's absence less.
Slightly less. And that is high praise.
Yes. I think Akida will be used as a voice detector accelerator with Nvidia for the in-cabin infotainment. The thing about key word spotting is that it is always on, and needs to process all sounds to pick out the key words.
Akida can also be used with the driver monitor (becoming compulsory in EU).
It is probably also in Valeo's Scala 3 lidar, but Luminar hopes to be used in MB lidar in a couple of years.
Scala 2 was also used in Toyota's level 3 qualification.
Rskiff
Regular
What about the other companies that entered the ASX200 at the same time, CXO is now .92 and NHC is $5.07.
MDhere
Regular
well not entirely. I as one of the disciples am on and off here for several reasons, 1. On here to read things 2. On here to post something i found interesting 3. Off as im busy 4. Off as i know that no matter what we write here, no matter what the price is doing, Brainchip will succeed so i sit back relax and I dont need to be 24/7 posting as i know I'm I am A Ok. i am sure all the other "disciples" are A Ok too and on and off here too. Hope that makes you guys feel a bit better that we are stil here. Kudos though for shouting out, just remember to believe in what you investing in. I do.
charmander
Regular
charmander
Regular
Smart Businesses Snap Up Vehicle Trackers (Quotes)
AdExpert Market
BrainChip Selects IPro Silicon IP to Serve Israel’s High Growth AI Market
Mon, June 26, 2023 at 7:30 AM GMT+10·4 min read
In this article:
- BRN.AX
-2.82%
- BCHPY
0.00%
- BRCHF
-7.32%
LAGUNA HILLS, Calif., June 25, 2023--(BUSINESS WIRE)--BrainChip Holdings Ltd (ASX: BRN, OTCQX: BRCHF, ADR: BCHPY), the world’s first commercial producer of ultra-low power, fully digital, event-based, neuromorphic AI IP, has selected IPro Silicon IP Ltd. to expand its sales presence in Israel.
IPro has served Israel’s chip design community through best-in-class IP partnerships and first-class support. As a trusted sales source, IPro collaborates with customers by learning their exacting needs and providing world-class products that enable them to reach the market with state-of-the-art solutions fast.
IPro will offer BrainChip’s first-to-market, fully digital neuromorphic processor IP, Akida™, as part of its portfolio to enable Edge AI processing with unparalleled performance, precision, and economy of energy. Akida’s fully customizable, event-based AI neural processor provides the scalable architecture and small footprint required to boost efficiency by orders of magnitude, allowing SoC designers to overlay any of the traditional dynamic voltage and frequency scaling for further optimization. Greater AI performance at the Edge, untethered from the cloud, is a key enabler for the growth of the Artificial Intelligence of Things (AIoT) market that is expected to be over a trillion dollars by 2030.
"We have a long tradition of partnering with IP leaders from around the world and ensuring successful implementations of their technology in our customers’ fabless designs," said Mauro Diamant, GM of IPro. "With the addition of Akida’s efficient edge AI architecture that is easy to evaluate, design, develop and deploy, we are enabling our customers to deliver more innovative Edge AI solutions. We are pleased that BrainChip has selected IPro to be its sales representative in Israel and look forward to our mutual success, as well as that of our customers."
"As BrainChip takes its leading AI technology into key new markets, it is imperative that we build local representation that can support customers and accelerate innovation," said Chris Stevens, BrainChip's Vice President of worldwide sales. "By joining forces with IPro, we are better positioned to serve the Israeli marketplace, delivering easy access to BrainChip’s Akida technology to this hotbed of technological innovation thereby accelerating the progress of AIoT."
Quatrojos
Regular
I wonder what happened with the Eastronics partnership announced 8 March 2022:
Smart Businesses Snap Up Vehicle Trackers (Quotes)
AdExpert Market
BrainChip Selects IPro Silicon IP to Serve Israel’s High Growth AI Market
Mon, June 26, 2023 at 7:30 AM GMT+10·4 min read
In this article:
- BRN.AX
-2.82%
- BCHPY
0.00%
- BRCHF
-7.32%
LAGUNA HILLS, Calif., June 25, 2023--(BUSINESS WIRE)--BrainChip Holdings Ltd (ASX: BRN, OTCQX: BRCHF, ADR: BCHPY), the world’s first commercial producer of ultra-low power, fully digital, event-based, neuromorphic AI IP, has selected IPro Silicon IP Ltd. to expand its sales presence in Israel.
IPro has served Israel’s chip design community through best-in-class IP partnerships and first-class support. As a trusted sales source, IPro collaborates with customers by learning their exacting needs and providing world-class products that enable them to reach the market with state-of-the-art solutions fast.
IPro will offer BrainChip’s first-to-market, fully digital neuromorphic processor IP, Akida™, as part of its portfolio to enable Edge AI processing with unparalleled performance, precision, and economy of energy. Akida’s fully customizable, event-based AI neural processor provides the scalable architecture and small footprint required to boost efficiency by orders of magnitude, allowing SoC designers to overlay any of the traditional dynamic voltage and frequency scaling for further optimization. Greater AI performance at the Edge, untethered from the cloud, is a key enabler for the growth of the Artificial Intelligence of Things (AIoT) market that is expected to be over a trillion dollars by 2030.
"We have a long tradition of partnering with IP leaders from around the world and ensuring successful implementations of their technology in our customers’ fabless designs," said Mauro Diamant, GM of IPro. "With the addition of Akida’s efficient edge AI architecture that is easy to evaluate, design, develop and deploy, we are enabling our customers to deliver more innovative Edge AI solutions. We are pleased that BrainChip has selected IPro to be its sales representative in Israel and look forward to our mutual success, as well as that of our customers."
"As BrainChip takes its leading AI technology into key new markets, it is imperative that we build local representation that can support customers and accelerate innovation," said Chris Stevens, BrainChip's Vice President of worldwide sales. "By joining forces with IPro, we are better positioned to serve the Israeli marketplace, delivering easy access to BrainChip’s Akida technology to this hotbed of technological innovation thereby accelerating the progress of AIoT."
BrainChip Continues Expansion with Sales Partnerships in New Geographic Markets
via Buisness Wire - announced new sales partnerships in Europe and Israel that will further expand the commercial reach of its Akida™
brainchip.com
This, for me, shows a lack of communication to shareholders...
supersonic001
Regular
BrainChip on LinkedIn: BrainChip Selects IPro Silicon IP to Serve Israel’s High Growth AI Market
BrainChip Selects IPro Silicon IP to Serve Israel’s high growth AI market https://lnkd.in/gA7M7EUW
For me it shows Eastronics weren't doing their job and have perhaps been dumped by BRN for a better option. Or we're now using both?I wonder what happened with the Eastronics partnership announced 8 March 2022:
BrainChip Continues Expansion with Sales Partnerships in New Geographic Markets
via Buisness Wire - announced new sales partnerships in Europe and Israel that will further expand the commercial reach of its Akida™
This, for me, shows a lack of communication to shareholders...
DollazAndSense
Regular
@TECH posted this a while back -I wonder what happened with the Eastronics partnership announced 8 March 2022:
BrainChip Continues Expansion with Sales Partnerships in New Geographic Markets
via Buisness Wire - announced new sales partnerships in Europe and Israel that will further expand the commercial reach of its Akida™
This, for me, shows a lack of communication to shareholders...
“About a month ago I asked the company, Tony in this case, why Eastronics had been removed from the company's website
and the answer that I received at the time didn't add up, or more to the point, actually make any sense.
So, I re-asked the question, and this was the response yesterday.
"I asked our CFO Ken Scarince, and he confirmed that we ended our relationship with Eastronics back in October. Further to Ken’s confirmation, Chris Stevens our VP of Sales confirmed via email that he terminated the relationship with Eastronics shortly after he came on board."
"I’m not going to provide specific reasons for the decision, but such decisions are taken for a variety of reasons including, but not limited to, budgetary considerations, strategic realignment and non-performance."”
DerAktienDude
Regular
Jesus Christ the website looks awful
"The system is constantly learning.." And there-in lies the spin.It's worth noting that the use case in this article is one which has been specifically mentioned by the company.
Early Forest Fire Detection Using Sensors
Silvanet, an early forest fire detection system, uses small sensors to prevent forest fires and protect people, animals, and the environment. Read more!bit.ly
View attachment 38871
View attachment 38874 View attachment 38875
We are meant to think that the chip learns. But of course it's connected to a server and needs to be trained, so no Akida.
In fact, it's just an example of a niche we missed out on.
FrederikSchack
Regular
Not even close to simple and it can take many years from discovery to production.
Damo4
Regular
Jesus Christ the website looks awful
Not a dig at Israel but a few of the companies I used to work with from there had similar styles of website.
I guess they just market things differently.
Similar threads
